Quinn Opportunity Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Hold |
464,513
| – | – | 0.12% | 155 |
|
|
2025
Q1 | $1.62M | Buy |
464,513
+59,634
| +15% | +$208K | 0.11% | 175 |
|
|
2024
Q4 | $1.32M | Buy |
404,879
+169,747
| +72% | +$555K | 0.09% | 165 |
|
|
2024
Q3 | $905K | Buy |
235,132
+70,000
| +42% | +$270K | 0.09% | 143 |
|
|
2024
Q2 | $510K | Buy |
+165,132
| New | +$510K | 0.06% | 166 |
|
|
2022
Q1 | – | Sell |
-276,485
| Closed | -$1.08M | – | 162 |
|
|
2021
Q4 | $1.08M | Buy |
+276,485
| New | +$1.08M | 0.07% | 139 |
|